Heparin-induced thrombocytopenia and cardiac surgery
- 1 August 2003
- journal article
- review article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 76 (2), 638-648
- https://doi.org/10.1016/s0003-4975(03)00756-2
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- An Assessment of Different Filter Systems for Extracorporeal Elimination of Bivalirudin: An In Vitro StudyAnesthesia & Analgesia, 2003
- Bivalirudin Monitored with the Ecarin Clotting Time for Anticoagulation During Cardiopulmonary BypassAnesthesia & Analgesia, 2003
- DanaparoidDrugs, 2002
- ArgatrobanDrugs, 2001
- Use of Heparin during Cardiopulmonary Bypass in Patients with a History of Heparin-Induced ThrombocytopeniaNew England Journal of Medicine, 2000
- A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type IIAdaptation of the ecarin clotting time to the Act II deviceThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Cardiovascular Surgery Without Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia Type II Using Anticoagulation with Recombinant HirudinAnesthesia & Analgesia, 2000
- Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operationsJournal of Vascular Surgery, 1998
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- “Heparin-free” Cardiopulmonary BypassAnesthesiology, 1990